Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes

Shumin Li, Xun Li, Hong Zheng, Bin Xie, Keshore R. Bidasee, George J. Rozanski

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aims: Transforming growth factor-β1 (TGF- β1) is a multifunctional cytokine that contributes to pathogenic cardiac remodelling via mechanisms that involve oxidative stress. However, the direct impact of TGF-β1 on contractile function of ventricular myocytes is incompletely understood. Methods and results: Reactive oxygen species (ROS) production and intracellular glutathione (GSH) were measured by fluorescence microscopy in isolated rat ventricular myocytes pretreated with TGF-β1 (0.1-10 ng/mL). In separate studies, video edge detection measurements were made to evaluate myocyte contractile function, and confocal microscopy was used to monitor evoked Ca2+ transients. TGF-β1 (1 ng/mL) for 3-4 h significantly increased ROS production by 90% (P < 0.05) and decreased GSH by 34% (P < 0.05) compared with control. These changes paralleled a significant decrease in the rate of myocyte shortening and relaxation by 33% and 43%, respectively (0.5 Hz; P < 0.05), whereas fractional shortening was not altered. Ca2+ transients in TGF-β1-treated myocytes were characterized by a delayed peak and slowing in the rate of decay but no change in peak Ca2+ amplitude. Increased ROS production and GSH depletion by TGF-β1 were prevented by an NAD(P)H oxidase inhibitor or a free radical scavenger, both of which significantly mitigated TGF-β1-induced myocyte contractile dysfunction. Moreover, pretreating myocytes with exogenous GSH or the GSH precursor N-acetylcysteine also prevented myocyte contractile impairment and abnormal Ca2+ transients elicited by TGF-β1. Conclusion: Our data suggest that TGF-β1-induced cardiomyocyte contractile dysfunction is associated with enhanced ROS production and oxidative alterations in Ca2+ handling proteins regulated by endogenous GSH.

Original languageEnglish (US)
Pages (from-to)107-117
Number of pages11
JournalCardiovascular research
Volume77
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Transforming Growth Factors
Muscle Cells
Reactive Oxygen Species
Free Radical Scavengers
Ventricular Function
NADPH Oxidase
Acetylcysteine
Fluorescence Microscopy
Cardiac Myocytes
Confocal Microscopy
Glutathione
Oxidative Stress
Cytokines

Keywords

  • Glutathione
  • NAD(P)H oxidase
  • Oxidative stress
  • Redox
  • TGF

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes. / Li, Shumin; Li, Xun; Zheng, Hong; Xie, Bin; Bidasee, Keshore R.; Rozanski, George J.

In: Cardiovascular research, Vol. 77, No. 1, 01.01.2008, p. 107-117.

Research output: Contribution to journalArticle

Li, Shumin ; Li, Xun ; Zheng, Hong ; Xie, Bin ; Bidasee, Keshore R. ; Rozanski, George J. / Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes. In: Cardiovascular research. 2008 ; Vol. 77, No. 1. pp. 107-117.
@article{4ed7de58cfd54f999d42dfb1b9f3280d,
title = "Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes",
abstract = "Aims: Transforming growth factor-β1 (TGF- β1) is a multifunctional cytokine that contributes to pathogenic cardiac remodelling via mechanisms that involve oxidative stress. However, the direct impact of TGF-β1 on contractile function of ventricular myocytes is incompletely understood. Methods and results: Reactive oxygen species (ROS) production and intracellular glutathione (GSH) were measured by fluorescence microscopy in isolated rat ventricular myocytes pretreated with TGF-β1 (0.1-10 ng/mL). In separate studies, video edge detection measurements were made to evaluate myocyte contractile function, and confocal microscopy was used to monitor evoked Ca2+ transients. TGF-β1 (1 ng/mL) for 3-4 h significantly increased ROS production by 90{\%} (P < 0.05) and decreased GSH by 34{\%} (P < 0.05) compared with control. These changes paralleled a significant decrease in the rate of myocyte shortening and relaxation by 33{\%} and 43{\%}, respectively (0.5 Hz; P < 0.05), whereas fractional shortening was not altered. Ca2+ transients in TGF-β1-treated myocytes were characterized by a delayed peak and slowing in the rate of decay but no change in peak Ca2+ amplitude. Increased ROS production and GSH depletion by TGF-β1 were prevented by an NAD(P)H oxidase inhibitor or a free radical scavenger, both of which significantly mitigated TGF-β1-induced myocyte contractile dysfunction. Moreover, pretreating myocytes with exogenous GSH or the GSH precursor N-acetylcysteine also prevented myocyte contractile impairment and abnormal Ca2+ transients elicited by TGF-β1. Conclusion: Our data suggest that TGF-β1-induced cardiomyocyte contractile dysfunction is associated with enhanced ROS production and oxidative alterations in Ca2+ handling proteins regulated by endogenous GSH.",
keywords = "Glutathione, NAD(P)H oxidase, Oxidative stress, Redox, TGF",
author = "Shumin Li and Xun Li and Hong Zheng and Bin Xie and Bidasee, {Keshore R.} and Rozanski, {George J.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1093/cvr/cvm022",
language = "English (US)",
volume = "77",
pages = "107--117",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Pro-oxidant effect of transforming growth factor-β1 mediates contractile dysfunction in rat ventricular myocytes

AU - Li, Shumin

AU - Li, Xun

AU - Zheng, Hong

AU - Xie, Bin

AU - Bidasee, Keshore R.

AU - Rozanski, George J.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Aims: Transforming growth factor-β1 (TGF- β1) is a multifunctional cytokine that contributes to pathogenic cardiac remodelling via mechanisms that involve oxidative stress. However, the direct impact of TGF-β1 on contractile function of ventricular myocytes is incompletely understood. Methods and results: Reactive oxygen species (ROS) production and intracellular glutathione (GSH) were measured by fluorescence microscopy in isolated rat ventricular myocytes pretreated with TGF-β1 (0.1-10 ng/mL). In separate studies, video edge detection measurements were made to evaluate myocyte contractile function, and confocal microscopy was used to monitor evoked Ca2+ transients. TGF-β1 (1 ng/mL) for 3-4 h significantly increased ROS production by 90% (P < 0.05) and decreased GSH by 34% (P < 0.05) compared with control. These changes paralleled a significant decrease in the rate of myocyte shortening and relaxation by 33% and 43%, respectively (0.5 Hz; P < 0.05), whereas fractional shortening was not altered. Ca2+ transients in TGF-β1-treated myocytes were characterized by a delayed peak and slowing in the rate of decay but no change in peak Ca2+ amplitude. Increased ROS production and GSH depletion by TGF-β1 were prevented by an NAD(P)H oxidase inhibitor or a free radical scavenger, both of which significantly mitigated TGF-β1-induced myocyte contractile dysfunction. Moreover, pretreating myocytes with exogenous GSH or the GSH precursor N-acetylcysteine also prevented myocyte contractile impairment and abnormal Ca2+ transients elicited by TGF-β1. Conclusion: Our data suggest that TGF-β1-induced cardiomyocyte contractile dysfunction is associated with enhanced ROS production and oxidative alterations in Ca2+ handling proteins regulated by endogenous GSH.

AB - Aims: Transforming growth factor-β1 (TGF- β1) is a multifunctional cytokine that contributes to pathogenic cardiac remodelling via mechanisms that involve oxidative stress. However, the direct impact of TGF-β1 on contractile function of ventricular myocytes is incompletely understood. Methods and results: Reactive oxygen species (ROS) production and intracellular glutathione (GSH) were measured by fluorescence microscopy in isolated rat ventricular myocytes pretreated with TGF-β1 (0.1-10 ng/mL). In separate studies, video edge detection measurements were made to evaluate myocyte contractile function, and confocal microscopy was used to monitor evoked Ca2+ transients. TGF-β1 (1 ng/mL) for 3-4 h significantly increased ROS production by 90% (P < 0.05) and decreased GSH by 34% (P < 0.05) compared with control. These changes paralleled a significant decrease in the rate of myocyte shortening and relaxation by 33% and 43%, respectively (0.5 Hz; P < 0.05), whereas fractional shortening was not altered. Ca2+ transients in TGF-β1-treated myocytes were characterized by a delayed peak and slowing in the rate of decay but no change in peak Ca2+ amplitude. Increased ROS production and GSH depletion by TGF-β1 were prevented by an NAD(P)H oxidase inhibitor or a free radical scavenger, both of which significantly mitigated TGF-β1-induced myocyte contractile dysfunction. Moreover, pretreating myocytes with exogenous GSH or the GSH precursor N-acetylcysteine also prevented myocyte contractile impairment and abnormal Ca2+ transients elicited by TGF-β1. Conclusion: Our data suggest that TGF-β1-induced cardiomyocyte contractile dysfunction is associated with enhanced ROS production and oxidative alterations in Ca2+ handling proteins regulated by endogenous GSH.

KW - Glutathione

KW - NAD(P)H oxidase

KW - Oxidative stress

KW - Redox

KW - TGF

UR - http://www.scopus.com/inward/record.url?scp=38849104982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849104982&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvm022

DO - 10.1093/cvr/cvm022

M3 - Article

C2 - 18006470

AN - SCOPUS:38849104982

VL - 77

SP - 107

EP - 117

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -